Vanguard Personalized Indexing Management
AUTL

Vanguard Personalized Indexing Management’s Autolus Therapeutics AUTL Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.1K Buy
16,960
+2,844
+20% +$4.46K ﹤0.01% 2190
2026
Q1 		$19.5K Sell
14,116
-3,631
-20% -$5.51K ﹤0.01% 2126
2025
Q4 		$35.3K Sell
17,747
-2,413
-12% -$3.71K ﹤0.01% 1910
2025
Q3 		$32.9K Sell
20,160
-10,272
-34% -$20.1K ﹤0.01% 1943
2025
Q2 		$69.4K Buy
30,432
+11,821
+64% +$19.5K ﹤0.01% 1784
2025
Q1 		$28.8K Buy
+18,611
New +$37.8K ﹤0.01% 1732

Other funds holding AUTL

MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Personalized Indexing Management's AUTL Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Autolus Therapeutics (AUTL) stake by 20% in Q2 2026, buying an estimated $4.46K and bringing the position to 16,960 shares worth $27.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2190.

Vanguard Personalized Indexing Management first reported a position in AUTL in Q1 2025 and has held it in 6 quarters since. The position peaked at $69.4K in Q2 2025. 84 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

  • Vanguard Personalized Indexing Management held 16,960 shares of Autolus Therapeutics worth $27.1K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 2,844 Autolus Therapeutics shares in Q2 2026, an estimated $4.46K.
  • Autolus Therapeutics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2190 holding.
  • Vanguard Personalized Indexing Management first reported a position in Autolus Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Vanguard Personalized Indexing Management's Autolus Therapeutics position peaked at $69.4K in Q2 2025.
  • 84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.